Forbes

Can Novavax Rise To The Manufacturing Challenge?

Can Novavax Rise To The Manufacturing Challenge?

Novavax published results of its U.S. phase 3 trials for its Covid-19 vaccine in mid-June, noting that the shot was over 90% effective overall and 100% effective against moderate and severe disease, roughly in line with Covid vaccine leaders such as Pfizer and Moderna. Although the shot is likely…

Source: Forbes – Markets
Date: July 8, 2021, 02:49